Furthermore, we also found that p38/MAPK pathway inhibitor not only weakened the function of FNDC5 to promote osteogenic differentiation in vitro, but also weakened the ameliorating effect of irisin on osteoporosis mice in vivo. The gene discussed is FNDC5; the disease is osteoporosis.